A Phase I Study To Estimate The Effect Of Ketoconazole And Omeprazole On The Pharmacokinetics Of Dimebon In Healthy Subjects Who Are Normal Or Poor CYP2D6 Metabolizers

NCT00931073 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease
Huntington's Disease

Interventions

DRUG: Dimebon alone
DRUG: Dimebon + Ketoconazole
DRUG: Dimebon + Omeprazole

Sponsor

Pfizer

Collaborators

[object Object]